Skip to main content

Advertisement

SpringerLink
Log in

Impact of Patient Age on the Postoperative Survival in Pancreatic Head Cancer

  • Pancreatic Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Some reports have stated that pancreatoduodenectomy for elderly patients have comparable morbidity and mortality to that of young patients. However, the long-term outcomes of these patients have not been fully evaluated, especially for pancreatic head cancer.

Methods

A total of 227 patients who underwent pancreatoduodenectomy for pancreatic head cancer between 2007 and 2014 were included. They were stratified according to age: young (<70 years), elderly (70 to <80 years), and very elderly (≥80 years). The short- and long-term outcomes were evaluated.

Results

There were no significant differences in terms of morbidity among the three groups. The median disease-free survival times were 15 months in the young, 11 months in the elderly, and 7 months in the very elderly. The disease-free survival of the young patients was significantly better than that in both the elderly and the very elderly (p = 0.012 and p = 0.016). The median overall survival times were 30 months in the young, 20 months in the elderly, and 14 months in the very elderly. The overall survival of the young patients was significantly better than that in both the elderly and the very elderly (p = 0.007 and p < 0.001). The difference was marginal between the elderly and the very elderly (p = 0.053). Multivariate analysis revealed that lymph node metastasis (p < 0.001), age ≥80 years (p = 0.013), lack of adjuvant chemotherapy (p = 0.003), blood transfusion (p = 0.015), and CA 19-9 ≥300 U/ml (p = 0.040) were significant prognostic factors.

Conclusions

Patient age influenced the survival after pancreatoduodenectomy for pancreatic cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. World report on ageing and health 2015. http://www.who.int/ageing/publications/world-report-2015/.

  2. Cancer Statistics in Japan. ublicat. http://ganjoho.jp/data/reg_stat/statistics/brochure/2015/cancer_statistics_2015.pdf.

  3. Gouma DJ, van Geenen RC, van Gulik TM, et al. Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume. Ann Surg. 2000;232(6):786–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. DeOliveira ML, Winter JM, Schafer M, et al. Assessment of complications after pancreatic surgery: a novel grading system applied to 633 patients undergoing pancreaticoduodenectomy. Ann Surg. 2006; 244(6):931–937; discussion 937–939.

    Article  PubMed  PubMed Central  Google Scholar 

  5. DiCarlo V, Balzano G, Zerbi A, Villa E. Pancreatic cancer resection in elderly patients. Br J Surg. 1998;85(5):607–10.

    Article  CAS  PubMed  Google Scholar 

  6. Petrowsky H, Clavien PA. Should we deny surgery for malignant hepato-pancreatico-biliary tumors to elderly patients? World J Surg. 2005;29(9):1093-100.

    Article  PubMed  Google Scholar 

  7. Ballarin R, Spaggiari M, Di Benedetto F, et al. Do not deny pancreatic resection to elderly patients. J Gastrointest Surg. 2009;13(2):341–8.

    Article  PubMed  Google Scholar 

  8. Sohn TA, Yeo CJ, Cameron JL, et al. Should pancreaticoduodenectomy be performed in octogenarians? J Gastrointest Surg. 1998;2(3):207–16.

    Article  CAS  PubMed  Google Scholar 

  9. Makary MA, Winter JM, Cameron JL, et al. Pancreaticoduodenectomy in the very elderly. J Gastrointest Surg. 2006;10(3):347–56.

    Article  PubMed  Google Scholar 

  10. Khan S, Sclabas G, Lombardo KR, et al. Pancreatoduodenectomy for ductal adenocarcinoma in the very elderly: is it safe and justified? J Gastrointest Surg. 2010;14(11):1826–31.

    Article  PubMed  Google Scholar 

  11. Tani M, Kawai M, Hirono S, et al. A pancreaticoduodenectomy is acceptable for periampullary tumors in the elderly, even in patients over 80 years of age. J Hepatobiliary Pancreat Surg. 2009;16(5):675–80.

    Article  PubMed  Google Scholar 

  12. Hatzaras I, Schmidt C, Klemanski D, et al. Pancreatic resection in the octogenarian: a safe option for pancreatic malignancy. J Am Coll Surg. 2011;212(3):373–7.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Oguro S, Shimada K, Kishi Y, et al. Perioperative and long-term outcomes after pancreaticoduodenectomy in elderly patients 80 years of age and older. Langenbeck’s Arch Surg. 2013;398(4):531–8.

    Article  Google Scholar 

  14. Lee MK, Dinorcia J, Reavey PL, et al. Pancreaticoduodenectomy can be performed safely in patients aged 80 years and older. J Gastrointest Surg. 2010;14(11):1838–46.

    Article  PubMed  Google Scholar 

  15. Melis M, Marcon F, Masi A, et al. The safety of a pancreaticoduodenectomy in patients older than 80 years: risk vs. benefits. HPB. 2012;14(9):583–8.

  16. Turrini O, Paye F, Bachellier P, et al. Pancreatectomy for adenocarcinoma in elderly patients: postoperative outcomes and long term results: a study of the French Surgical Association. Eur J Surg Oncol. 2013;39(2):171–8.

    Article  CAS  PubMed  Google Scholar 

  17. NCCN Clinical Practice Guidelines in Oncology: Pancreatic adenocarcinoma, version 2. 2016. https://www.nccn.org/professionals/physician_gls/pdf/pancreatic.pdf.

  18. Bassi C, Dervenis C, Butturini G, et al. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery. 2005;138(1):8–13.

    Article  PubMed  Google Scholar 

  19. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004; 240(2):205–213.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Sobin L, Gosporarowicz M, Wittekind C. TNM classification of malignant tumors (7th edn). New York: Wiley-Blackwell, 2009.

    Google Scholar 

  21. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297(3):267–77.

    Article  CAS  PubMed  Google Scholar 

  22. Uesaka K, Boku N, Fukutomi A, et al. Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01). Lancet. 2016;388(10041):248–57.

    Article  CAS  PubMed  Google Scholar 

  23. World Health Statistics 2015. 2015. http://www.who.int/gho/publications/world_health_statistics/2015/en/.

  24. Finlayson E, Fan Z, Birkmeyer JD. Outcomes in octogenarians undergoing high-risk cancer operation: a national study. J Am Coll Surg. 2007;205(6):729–34.

    Article  PubMed  Google Scholar 

  25. Riall TS, Reddy DM, Nealon WH, Goodwin JS. The effect of age on short-term outcomes after pancreatic resection: a population-based study. Ann Surg. 2008;248(3):459–67.

    PubMed  PubMed Central  Google Scholar 

  26. Sho M, Murakami Y, Kawai M, et al. Prognosis after surgical treatment for pancreatic cancer in patients aged 80 years or older: a multicenter study. J Hepatobiliary Pancreat Sci. 2016;23(3):188–97.

    Article  PubMed  Google Scholar 

  27. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350(12):1200-10.

    Article  CAS  PubMed  Google Scholar 

  28. Kinoshita S, Sho M, Yanagimoto H, et al. Potential role of surgical resection for pancreatic cancer in the very elderly. Pancreatology. 2015;15(3):240–6.

    Article  PubMed  Google Scholar 

  29. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364(19):1817–25.

    Article  CAS  PubMed  Google Scholar 

  30. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine. N Engl J Med. 2013;369(18):1691–703.

    Article  Google Scholar 

  31. Sugiura T, Uesaka K, Kanemoto H, et al. Serum CA19-9 is a significant predictor among preoperative parameters for early recurrence after resection of pancreatic adenocarcinoma. J Gastrointest Surg. 2012;16(5):977–85.

    Article  PubMed  Google Scholar 

  32. Yang JJ, Hu ZG, Shi WX, et al. Prognostic significance of neutrophil to lymphocyte ratio in pancreatic cancer: a meta-analysis. World J Gastroenterol. 2015;21(9):2807–15.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Kanda M, Fujii T, Kodera Y, et al. Nutritional predictors of postoperative outcome in pancreatic cancer. Br J Surg. 2011;98(2):268–74.

    Article  CAS  PubMed  Google Scholar 

  34. Yamada S, Fujii T, Yabusaki N, et al. Clinical implication of inflammation-based prognostic score in pancreatic cancer: Glasgow Prognostic Score is the most reliable parameter. Medicine. 2016; 95(18):e3582.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Disclosure

The authors declare no financial or any other type of support.

Author information

Authors and Affiliations

  1. Division of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center, Shizuoka, Japan

    Teiichi Sugiura MD, Y. Okamura MD, T. Ito MD, Y. Yamamoto MD, R. Ashida MD & K. Uesaka MD

Authors
  1. Teiichi Sugiura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Okamura MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T. Ito MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y. Yamamoto MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. R. Ashida MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. K. Uesaka MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Teiichi Sugiura MD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sugiura, T., Okamura, Y., Ito, T. et al. Impact of Patient Age on the Postoperative Survival in Pancreatic Head Cancer. Ann Surg Oncol 24, 3220–3228 (2017). https://doi.org/10.1245/s10434-017-5994-0

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-017-5994-0

Keywords

Search

Navigation